ENO1 and cancer: In a second SERPA study, when sera from PDA, non-PDA cancer, chronic pancreatitis, autoimmune disease patients and healthy subjects were compared in terms of antibody reactivity, six isoforms of ENO1 with the same molecular weight but different isoelectric points, were identified [6].